European Archives - Page 545 of 1100 - European Medical Journal

Treating Ankylosing Spondylitis Using Engineered JAK Inhibitor: Upadacitinib

Researchers explored the efficacy of upadacitinib in treating AS. Upadacitinib targets the inflammatory pathway and works by inhibiting JAK, reducing the ability of JAK to cause inflammation in the joints.

Effective Novel Drug for Axial Psoriatic Arthritis

Phase III clinical trials analysed the efficaPhase III clinical trials analysed the efficacy of a novel antibody, guselkumab, for psoriatic arthritis with axial symptoms.

Two Pilots Walk into a Pharmacy

We discuss the role of pharmacists on hospital wards, explore microbial stewardship, consider the evidence behind aspirin as a prevention tool.

Webinar: Acute MSK pain: how to manage symptoms and stress

Musculoskeletal (MSK) pain and soft tissue injuries are very common both in sportspeople and in the general population and include different forms of traumas that must be properly treated to allow the return to normal life or sports activities.

Talking to Jennifer Cain Birkmose

Jennifer Cain Birkmose, Senior Pharmaceutical Leader in Market Access, Patient Access, and Patient Advocacy, discusses clinical trials.

Hematology 9.1 Journal feature image

Review of the European Hematology Association (EHA) 2021 Virtual Congress

THE GLOBAL community of clinicians and researchers shared in the latest advances in haematology care online at the 26th European Hematology Association (EHA) 2021 Virtual Congress.

Hematology 9.1 Journal feature image

EMJ Hematology 9.1 2021

Welcome to the latest issue of EMJ Hematology. We are excited to share with you an impressive collection of new and interesting research, alongside our independent review of the European Hematology Association (EHA) 2021 Virtual Congress with the fascinating updates from the event.

Hematology 9.1 Journal feature image

Diagnosis, Treatment, Impact, and Unmet Needs of People with Mycosis Fungoides and Sézary Syndrome

Mycosis fungoides (MF) and Sézary syndrome (SS), two of the most-studied types of cutaneous T-cell lymphoma (CTCL), account for approximately 60% and 10% of CTCL cases, respectively.

Hematology 9.1 Journal feature image

COVID-19 in Patients with Acute Leukaemia: The Experience of a Haematological Centre

Patients with haematologic malignancies appear to have a greater risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and severe disease due to myelosuppression.

EULAR Interview: Ruud Delwel

EMJ sits down with Ruud Delwel, Chair of  the Scientific Program Committee, European Hematology Association (EHA) 2021 Virtual Congress.